.navithadev reports the latest research on biologic therapy in patients with asthma as presented at CHEST2022.
Dr Navitha Ramesh, of the University of Pittsburgh Medical Center in Harrisburg, Pennsylvania, reports the latest research on biologic therapy in patients withDr Ramesh highlights a clinical study evaluating whether stopping, restarting, or continuing biologic therapy affects clinical outcomes and healthcare resource utilization for patients with severe asthma.
for patients with severe eosinophilic asthma over 24 months. The study found that benralizumab is an effective long-term treatment for reducing asthma exacerbations in this patient population. Finally, Dr Ramesh examines two studies analyzing data from the phase 3 NAVIGATOR trial. The first study looked at patients treated with tezepelumab and one, two, or three additional controller medications at baseline. The results indicated that irrespective of the number of additional controller medications the patient received, tezepelumab was effective.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
North Texas High School Football 2022 Bi-District Playoff HighlightsThe high school football season always seems to fly by and here we are again. The post-season has arrived and there's nothing quite like playoff time in the state of Texas.
Read more »
2022-23 Central Texas high school football highlights, scores: Bi-district playoffsThe regular season has ended and teams are looking to advance as playoffs get underway.
Read more »
Analysis | In election 2022, the party of Trump pays for being the party of TrumpRepublicans went into the week looking to take control of the U.S. House and possibly the Senate. Instead, they are left more with questions than favorable results.
Read more »